PUBLICATION

Multiplex Analysis Platform for Endocrine Disruption Prediction Using Zebrafish

Authors
Jarque, S., Ibarra, J., Rubio-Brotons, M., García-Fernández, J., Terriente, J.
ID
ZDB-PUB-190411-2
Date
2019
Source
International Journal of Molecular Sciences   20(7): (Journal)
Registered Authors
de Txintxetru, Jone Ibarra Otsoa, Fernandez, Jessica Garcia, Ortiz, Sergio Jarque, Terriente, Javier
Keywords
androgens, endocrine disruption, estrogens, thyroid, transcriptomics, zebrafish
MeSH Terms
  • Androgens/analysis
  • Animals
  • Biological Assay/methods*
  • Endocrine Disruptors/toxicity*
  • Endocrine System/drug effects
  • Endocrine System/metabolism
  • Estrogens/analysis
  • Gene Expression Regulation, Developmental/drug effects
  • Gene Expression Regulation, Developmental/genetics
  • Transcriptome/genetics*
  • Zebrafish
PubMed
30965663 Full text @ Int. J. Mol. Sci.
Abstract
Small fish are an excellent experimental model to screen endocrine-disrupting compounds, but current fish-based assays to detect endocrine disruption have not been standardized yet, meaning that there is not consensus on endpoints and biomarkers to be measured. Moreover, exposure conditions may vary depending on the species used as the experimental model and the endocrine pathway evaluated. At present, a battery of a wide range of assays is usually needed for the complete assessment of endocrine activities. With the aim of providing a simple, robust, and fast assay to assess endocrine-disrupting potencies for the three major endocrine axes, i.e., estrogens, androgens, and thyroid, we propose the use of a panel of eight gene expression biomarkers in zebrafish larvae. This includes brain aromatase (cyp19a1b) and vitellogenin 1 (vtg1) for estrogens, cytosolic sulfotransferase 2 family 2 (sult2st3) and cytochrome P450 2k22 (cyp2k22) for androgens, and thyroid peroxidase (tpo), transthyretin (ttr), thyroid receptor α (trα), and iodothyronine deiodinase 2 (dio2) for thyroid metabolism. All of them were selected according to their responses after exposure to the natural ligands 17β-estradiol, testosterone, and 3,3',5-triiodo-L-thyronine (T3), respectively, and subsequently validated using compounds reported as endocrine disruptors in previous studies. Cross-talk effects were also evaluated for all compounds.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping